Metronidazole and the immune system

Pharmazie

Volumn 66, Issue 6, 2011, Pages 393-398

  Shakir, L ^a   Javeed, Aqeel ^a   Ashraf, M ^a   Riaz, A ^a  

^a UNIVERSITY OF VETERINARY AND ANIMAL SCIENCES   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CIPROFLOXACIN; DOXYCYCLINE; MEBENDAZOLE; METRONIDAZOLE; NITROIMIDAZOLE; SALAZOSULFAPYRIDINE; TETRACYCLINE;

ADAPTIVE IMMUNITY; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BACTERIAL INFECTION; CHRONIC PERIODONTITIS; CLINICAL TRIAL; DELAYED HYPERSENSITIVITY; DRUG MECHANISM; ENTERITIS; GIARDIASIS; GRAFT VERSUS HOST REACTION; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; NEUTROPHIL; NONHUMAN; REVIEW;

ADAPTIVE IMMUNITY; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIPROTOZOAL AGENTS; GRAFT VS HOST DISEASE; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNITY; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNITY, INNATE; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MACROPHAGES; METRONIDAZOLE; NEUTROPHILS;

EID: 79959947965     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.0790     Document Type: Review

References (77)

1. Akamatsu H, Horio T (1998) The possible role of reactive oxygen species generated by neutrophils in mediating acne inflammation. Dermatology 196: 82-85. (Pubitemid 28116048)
2. Akamatsu H, Oguchi M, Nishijima S, Asada Y, Takahashi M, Ushijima T and Niwa Y (1990) The inhibition of free radical generation by human neutrophils through the synergistic effects of metronidazole with palmitoleic acid: a possible mechanism of action of metronidazole in rosacea and acne. Arch Dermatol Res 282: 449-454. (Pubitemid 20350067)
3. Akyol D, Mungan T, Baltaci V (2000) A comparative study of genotoxic effects in the treatment of trichomonas vaginalis infection: metronidazole or nalidixic acid. Arch Gynecol Obstet 264: 20-23.
4. Amar S, Wu SC, Madan M (2009) Is Porphyromonas gingivalis cell invasion required for atherogenesis? Pharmacotherapeutic implications. J Immunol 182: 1584-1592.
5. Anderson R, Oosthuizen R, Maritz C, Theron A and Van Rensburg AJ (1979) Effects of metronidazole on certain functions of human blood neutrophils and lymphocytes. S Afr Med J 55: 593-596. (Pubitemid 9176010)
6. Arndt H, Palitzsch KD, Grisham MB and Granger DN (1994) Metronidazole inhibits leukocyte-endothelial cell adhesion in rat mesenteric venules. Gastroenterology 106: 1271-1276. (Pubitemid 24129244)
7. Bahr V, Ullmann U (1983) The influence of metronidazole and its two main metabolites on murine in vitro lymphocyte transformation. Eur J Clin Microbiol 2: 568-570.
8. Bamias G, Marini M, Moskaluk CA, Odashima M, Ross WG, Rivera-Nieves J, Cominelli F (2002) Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease. J Immunol 169: 5308-5314. (Pubitemid 35217204)
9. Bannatyne RM (1999) Metronidazole,;1; its bioactive metabolites and acne. Curr Med Res Opin 15: 298-299.
10. Bayraktar MR, Mehmet N, Durmaz R (2005) Serum cytokine changes in Turkish children infected with Giardia lamblia with and without allergy: Effect of metronidazole treatment. Acta Trop 95: 116-122. (Pubitemid 40943362)
11. Beelen DW, Elmaagacli A, Muller KD, Hirche H, Schaefer UW (1999) Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial. Blood 93: 3267-3275. (Pubitemid 29220893)
12. Belardelli F, Ferrantini M (2002) Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol 23: 201-208. (Pubitemid 34260936)
13. Bell AJ, Nicholls RJ, Forbes A, Ellis HJ, Ciclitira PJ (2004) Human lymphocyte stimulation with pouchitis flora is greater than with flora from a healthy pouch but is suppressed by metronidazole. Gut 53: 1801-1805. (Pubitemid 39556900)
14. Beutler B (2004) Innate immunity: an overview. Mol Immunol 40: 845-859.
15. Bjarnason I, Hayllar J, Smethurst P, Price A, Gumpel MJ (1992) Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut 33: 1204-1208.
16. Blum KS, Pabst R (2007) Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs? Immunol Lett 108: 45-51.
17. Bowdish DM, Loffredo MS, Mukhopadhyay S, Mantovani A, Gordon S (2007) Macrophage receptors implicated in the "adaptive" form of innate immunity. Microbes Infect 9: 1680-1687.
18. Carballo MA, Palermo AM, Mudry MD (2004) Toxicogenetic evaluation of metronidazole in the treatment of women infected with Trichomonas vaginalis. Ann Trop Med Parasitol 98: 139-147. (Pubitemid 38388882)
19. Celik A, Aras Ates N (2006) The frequency of sister chromatid exchanges in cultured human peripheral blood lymphocyte treated with metronidazole in vitro. Drug Chem Toxicol 29: 85-94. (Pubitemid 43292237)
20. Dilger K, Fux R, Rock D, Morike K, Gleiter CH (2007) Effect of high-dose metronidazole on pharmacokinetics of oral budesonide and vice versa: a double drug interaction study. J Clin Pharmacol 47: 1532-1539. (Pubitemid 350115305)
21. Elizondo G, Ostrosky-Wegman P (1996) Effects of metronidazole and its metabolites on histamine immunosuppression activity. Life Sci 59: 285-297.
22. Elizondo G, Montero R, Herrera JE, Hong E, Ostrosky-Wegman P (1994) Lymphocyte proliferation kinetics and sister-chromatid exchanges in individuals treated with metronidazole. Mutat Res 305: 133-137. (Pubitemid 24082887)
23. Elizondo G, Gonsebatt ME, Salazar AM, Lares I, Santiago P, Herrera J, Hong E, Ostrosky-Wegman P (1996) Genotoxic effects of metronidazole. Mutat Res 370: 75-80. (Pubitemid 26343817)
24. Fahrig R, Engelke M (1997) Reinvestigation of in vivo genotoxicity studies in man. I. No induction of DNA strand breaks in peripheral lymphocytes after metronidazole therapy. Mutat Res 395: 215-221.
25. Fararjeh M, Mohammad MK, Bustanji Y, Alkhatib H, Abdalla S (2008) Evaluation of immunosuppression induced by metronidazole in Balb/c mice and human peripheral blood lymphocytes. Int Immunopharmacol 8: 341-350.
26. Fitzpatrick LR, Small J, Hoerr RA, Bostwick EF, Maines L, Koltun WA (2008) In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: immunomodulation and attenuation of murine colitis. Br J Nutr 100: 530-541.
27. Fowler JF, Jr. (2007) Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea. J Drugs Dermatol 6: 641-645.
28. Galmier MJ, Frasey AM, Bastide M, Beyssac E, Petit J, Aiache JM, Lartigue-Mattei C (1998) Simple and sensitive method for determination of metronidazole in human serum by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 720: 239-243. (Pubitemid 29000953)
29. Gomez-Arroyo S, Melchor-Castro S, Villalobos-Pietrini R, Camargo EM, Salgado-Zamora H, Campos Aldrete ME (2004) Cytogenetic study of metronidazole and three metronidazole analogues in cultured human lymphocytes with and without metabolic activation. Toxicol in vitro 18: 319-324. (Pubitemid 38376365)
30. Grove DI, Mahmound AA, Warren KS (1977) Suppression of cell-mediated immunity by metronidazole. Int Arch Allergy Appl Immunol 54: 422-427. (Pubitemid 8135107)
31. Guthery SL, Heubi JE, Filipovich A (2004) Enteral metronidazole for the prevention of graft versus host disease in pediatric marrow transplant recipients: results of a pilot study. Bone Marrow Transplant 33: 1235-1239. (Pubitemid 38961483)
32. Hand WL, King-Thompson NL (1989) The entry of antibiotics into human monocytes. J Antimicrob Chemother 23: 681-689. (Pubitemid 19142289)
33. Hand WL, King-Thompson N, Holman JW (1987) Entry of roxithromycin (RU 965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes. Antimicrob Agents Chemother 31: 1553-1557. (Pubitemid 17140810)
34. Hanson WL (1981) Chemotherapy and the immune response in protozoal infections. J Protozool 28: 27-30.
35. Hartley-Asp B (1981) Metronidazole: absence of mammalian cytogenicity. Scand J Infect Dis Suppl 26: 72-74.
36. Hopkins SJ (2003) The pathophysiological role of cytokines. Leg Med (Tokyo) 5 Suppl 1: S45-57.
37. Knight RC, Skolimowski IM, Edwards DI (1978) The interaction of reduced metronidazole with DNA. Biochem Pharmacol 27: 2089-2093. (Pubitemid 9032775)
38. Korbelik M, Horvat D (1980) The mutagenicity of nitroaromatic drugs: effect of metronidazole after incubation in hypoxia in vitro. Mutat Res 78: 201-207. (Pubitemid 10111666)
39. Krehmeier U, Bardenheuer M, Voggenreiter G, Obertacke U, Schade FU, Majetschak M (2002) Effects of antimicrobial agents on spontaneous and endotoxin-induced cytokine release of human peripheral blood mononuclear cells. J Infect Chemother 8: 194-197. (Pubitemid 34839324)
40. Kunikata T, Tatefuji T, Aga H, Iwaki K, Ikeda M, Kurimoto M (2000) Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity. Eur J Pharmacol 410: 93-100. (Pubitemid 32008134)
41. Lambert B, Lindblad A, Ringborg U (1979). Absence of genotoxic effects of metronidazole and two of its urinary metabolites on human lymphocytes in vitro. Mutat Res 67: 281-287. (Pubitemid 9208847)
42. Le Bon A, Tough DF (2002) Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 14: 432-436. (Pubitemid 34671244)
43. Lefebvre Y, Hesseltine HC (1965) The peripheral white blood cells and metronidazole. Jama 194: 15-18.
44. Lehmann C, Bac VH, Pavlovic D, Lustig M, Maier S, Feyerherd F, Usichenko TI, Meissner K, Haase H, Junger M, Wendt M, Heidecke CD, Grundling M (2006) Metronidazole improves intestinal microcirculation in septic rats independently of bacterial burden. Clin Hemorheol Microcirc 34: 427-438.
45. Lichtman SN, Keku J, Schwab JH and Sartor RB (1991) Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth. Infect Immun 59: 555-562.
46. Lopez Nigro MM, Palermo AM, Mudry MD and Carballo MA (2003) Cytogenetic evaluation of two nitroimidazole derivatives. Toxicol in vitro 17: 35-40. (Pubitemid 36106489)
47. Menendez D, Bendesky A, Rojas E, Salamanca F, Ostrosky-Wegman P (2002) Role of P53 functionality in the genotoxicity of metronidazole and its hydroxy metabolite. Mutat Res 501: 57-67. (Pubitemid 34270651)
48. Menendez D, Rojas E, Herrera LA, Lopez MC, Sordo M, Elizondo G, Ostrosky-Wegman P (2001) DNA breakage due to metronidazole treatment. Mutat Res 478: 153-158. (Pubitemid 32530860)
49. Mercer-Jones MA, Hadjiminas DJ, Heinzelmann M, Peyton J, Cook M, Cheadle WG (1998) Continuous antibiotic treatment for experimental abdominal sepsis: effects on organ inflammatory cytokine expression and neutrophil sequestration. Br J Surg 85: 385-389. (Pubitemid 28098630)
50. Miller JJ, Reeves SC, Salaman JR (1980) Effects of simple imidazoles on human peripheral blood lymphocytes stimulated by mitogen or allogeneic cells. J Immunopharmacol 2: 225-243. (Pubitemid 11190079)
51. Millikan L (2003) The proposed inflammatory pathophysiology of rosacea: implications for treatment. Skinmed 2: 43-47.
52. Mitelman F, Strombeck B, Ursing B, Nordle O, Hartley-Asp B (1982) Metronidazole exhibits no clastogenic activity in a double-blind crossover study on Crohn's patients. Hereditas 96: 279-286. (Pubitemid 12028037)
53. Miyachi Y (2001) Potential antioxidant mechanism of action for metronidazole: implications for rosacea management. Adv Ther 18: 237-243.
54. Miyachi Y, Imamura S, Niwa Y (1986) Anti-oxidant action of metronidazole: a possible mechanism of action in rosacea. Br J Dermatol 114: 231-234. (Pubitemid 16131430)
55. Moreno-Fierros L, Lopez-Revilla R, Nunez EI (2000) Metronidazole and mebendazole pretreatments suppress the antiamebic recognition of lamina propia lymphocyte supernatants from the small and large intestine in intraperitoneally immunized Balb/c mice. Arch Med Res 31: S116-118.
56. Mudry MD, Carballo M, Labal de Vinuesa M, Gonzalez Cid M, Larripa I (1994) Mutagenic bioassay of certain pharmacological drugs: III. Metronidazole (MTZ). Mutat Res 305: 127-132. (Pubitemid 24082886)
57. Narayanan S, Hunerbein A, Getie M, Jackel A, Neubert RH (2007) Scavenging properties of metronidazole on free oxygen radicals in a skin lipid model system. J Pharm Pharmacol 59: 1125-1130. (Pubitemid 47265360)
58. Nishimuta K, Ito Y (2003) Effects of metronidazole and tinidazole ointments on models for inflammatory dermatitis in mice. Arch Dermatol Res 294: 544-551. (Pubitemid 36384684)
59. Re JL, De Meo MP, Laget M, Guiraud H, Castegnaro M, Vanelle P, Dumenil G (1997) Evaluation of the genotoxic activity of metronidazole and dimetridazole in human lymphocytes by the comet assay. Mutat Res 375: 147-155. (Pubitemid 27226693)
60. Rege NN, Dahanukar SA (1993) Quantitation of microbicidal activity of mononuclear phagocytes: an in vitro technique. J Postgrad Med 39: 22-25.
61. Reitz M, Rumpf M. Knitza R (1991a) DNA single strand-breaks in lymphocytes after metronidazole therapy. Arzneimittelforschung 41: 155-156.
62. Reitz M, Rumpf M, Knitza R (1991b) Metronidazole induces DNA strand-breaks in cultures of human lymphocytes and phytohemagglutinin-stimulated human lymphocytes. Arzneimittelforschung 41: 65-69.
63. Rockwell S, Irvin CG, Neaderland MH (1983) Inhibition of delayed hypersensitivity by metronidazole and misonidazole. Int J Radiat Oncol Biol Phys 9: 701-706. (Pubitemid 13106635)
64. Rodriguez Ferreiro G, Cancino Badias L, Lopez-Nigro M, Palermo A, Mudry M, Gonzalez Elio P, Carballo MA (2002) DNA single strand breaks in peripheral blood lymphocytes induced by three nitroimidazole derivatives. Toxicol Lett 132: 109-115. (Pubitemid 34607168)
65. Roe FJ (1983) Toxicologic evaluation of metronidazole with particular reference to carcinogenic, mutagenic, and teratogenic potential. Surgery 93: 158-164.
66. Roe FJ (1985) Safety of nitroimidazoles. Scand J Infect Dis Suppl 46:72-81.
67. Savilahti E, Kirveskari J, Jarvinen A, Tervo T, Renkonen R (2004) Monitoring leukocyte traffic in vivo into human delayed-type hypersensitivity reaction. J Immunol Methods 288: 81-89.
68. Sekis I, Ramstead K, Rishniw M, Schwark WS, McDonough SP, Goldstein RE, Papich M, Simpson KW (2009) Single-dose pharmacokinetics and genotoxicity of metronidazole in cats. J Feline Med Surg 11: 60-68.
69. Sen P, Chakravarty AK, Kohli J (1991) Effects of some imidazoles on cellular immune responses-an experimental study. Indian J Exp Biol 29: 867-869.
70. Shchepetkin IA, Iur'ev S (1998) [Effect of metronidazole on luminol dependent chemiluminescence of neutrophils in whole blood of patients with chlamydial infection]. Antibiot Khimioter 43: 31-36.
71. Shimizu K, Koga H, Iida M, Yao T, Hirakawa K, Hoshika K, Mikami Y, Haruma K (2002) Does metronidazole cure cap polyposis by its antiinflammatory actions instead of by its antibiotic action? A case study. Dig Dis Sci 47: 1465-1468. (Pubitemid 34753921)
72. Shroit IG, Anisimova LA, Khodyreva GD, Kozliuk AS, Bukova VE (1986) [Effect of metronidazole on the course of experimental anaerobic streptococcal pneumonia]. Zh Mikrobiol Epidemiol Immunobiol: 21-24.
73. Theobald M (1995) Predicting graft-versus-host disease. Curr Opin Immunol 7: 649-655.
74. Tsai TH, Chen YF (2003) Pharmacokinetics of metronidazole in rat blood, brain and bile studied by microdialysis coupled to microbore liquid chromatography. J Chromatogr A 987: 277-282.
75. Yamada T, Deitch E, Specian RD, Perry MA, Sartor RB, Grisham MB (1993) Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 17: 641-662. (Pubitemid 23359088)
76. Yawalkar N, Reimers A, Hari Y, Hunziker T, Gerber H, Muller U, Pichler W (1999) Drug-induced linear IgA bullous dermatosis associated with ceftriaxone- and metronidazole-specific T cells. Dermatology 199: 25-30. (Pubitemid 29366783)
77. Yudin MH, Landers DV, Meyn L, Hillier SL (2003) Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial. Obstet Gynecol 102: 527-534. (Pubitemid 37311216)